Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.
Adolescent
Alleles
Child
Female
Humans
Immunity
Infant
Inheritance Patterns
/ genetics
Interferon Type I
/ metabolism
Male
Measles Vaccine
/ adverse effects
Mutant Proteins
/ metabolism
Mutation
/ genetics
Pedigree
Receptor, Interferon alpha-beta
/ deficiency
Signal Transduction
Yellow Fever Vaccine
/ adverse effects
Journal
The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R
Informations de publication
Date de publication:
02 09 2019
02 09 2019
Historique:
received:
12
12
2018
revised:
18
03
2019
accepted:
11
06
2019
pubmed:
5
7
2019
medline:
11
6
2020
entrez:
5
7
2019
Statut:
ppublish
Résumé
Vaccination against measles, mumps, and rubella (MMR) and yellow fever (YF) with live attenuated viruses can rarely cause life-threatening disease. Severe illness by MMR vaccines can be caused by inborn errors of type I and/or III interferon (IFN) immunity (mutations in
Identifiants
pubmed: 31270247
pii: jem.20182295
doi: 10.1084/jem.20182295
pmc: PMC6719432
doi:
Substances chimiques
IFNAR1 protein, human
0
Interferon Type I
0
Measles Vaccine
0
Mutant Proteins
0
Yellow Fever Vaccine
0
Receptor, Interferon alpha-beta
156986-95-7
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2057-2070Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM066699
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI137371
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI111825
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007739
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI057229
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001866
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124690
Pays : United States
Informations de copyright
© 2019 Hernandez et al.
Références
J Pediatr. 1999 Nov;135(5):640-3
pubmed: 10547254
Science. 2000 Jun 30;288(5475):2357-60
pubmed: 10875919
Int J Tuberc Lung Dis. 2000 Aug;4(8):791-4
pubmed: 10949334
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
J Virol. 2002 Dec;76(24):13001-14
pubmed: 12438626
EMBO J. 2003 Feb 3;22(3):537-47
pubmed: 12554654
Nat Genet. 2003 Mar;33(3):388-91
pubmed: 12590259
J Gen Virol. 2003 May;84(Pt 5):1261-8
pubmed: 12692292
J Immunol. 2004 Sep 15;173(6):4000-8
pubmed: 15356149
Immunity. 2005 Feb;22(2):247-57
pubmed: 15723812
J Immunol. 2006 Apr 15;176(8):5078-83
pubmed: 16585605
Immunity. 2006 Sep;25(3):349-60
pubmed: 16979567
Immunity. 2006 Nov;25(5):745-55
pubmed: 17088085
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
J Infect Dis. 2008 Aug 15;198(4):500-7
pubmed: 18598196
Am J Hum Genet. 2008 Sep;83(3):359-72
pubmed: 18760389
Nat Immunol. 2009 Jan;10(1):116-125
pubmed: 19029902
J Exp Med. 2008 Dec 22;205(13):3119-31
pubmed: 19047440
Mem Inst Oswaldo Cruz. 2008 Nov;103(7):711-8
pubmed: 19057823
Hum Gene Ther. 2009 Aug;20(8):845-60
pubmed: 19419274
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
N Engl J Med. 2009 Nov 19;361(21):2033-45
pubmed: 19890111
Clin Vaccine Immunol. 2010 Jan;17(1):118-26
pubmed: 19906894
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Mol Biol Evol. 2011 Jan;28(1):63-70
pubmed: 20837603
N Engl J Med. 2011 Apr 7;364(14):1326-33
pubmed: 21470010
Cell. 1990 Jan 26;60(2):225-34
pubmed: 2153461
Vaccine. 2011 Aug 26;29(37):6327-34
pubmed: 21640779
Blood. 2011 Aug 18;118(7):1806-17
pubmed: 21772053
J Immunol. 2012 Feb 15;188(4):1915-23
pubmed: 22246627
Curr Opin Immunol. 2012 Aug;24(4):364-78
pubmed: 22651901
Immunol Rev. 2012 Nov;250(1):317-34
pubmed: 23046138
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3053-8
pubmed: 23391734
Nat Immunol. 2013 Sep;14(9):901-7
pubmed: 23872679
J Virol. 2013 Nov;87(22):12392-7
pubmed: 24027319
Blood. 2013 Nov 28;122(23):3713-22
pubmed: 24089328
Immunol Invest. 2014;43(3):292-8
pubmed: 24294834
Am J Trop Med Hyg. 2014 Feb;90(2):267-71
pubmed: 24394480
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Vaccine. 2015 Jan 1;33(1):62-72
pubmed: 25446819
J Clin Virol. 2015 Mar;64:160-73
pubmed: 25453327
Science. 2015 Apr 24;348(6233):448-53
pubmed: 25814066
Vaccine. 2015 Aug 20;33(35):4261-8
pubmed: 25862300
Brain. 2015 Oct;138(Pt 10):2834-46
pubmed: 26122121
J Exp Med. 2015 Sep 21;212(10):1641-62
pubmed: 26304966
Sci Transl Med. 2015 Sep 30;7(307):307ra154
pubmed: 26424569
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13615-20
pubmed: 26483451
Nat Methods. 2016 Feb;13(2):109-10
pubmed: 26820543
MBio. 2016 Feb 09;7(1):e01956-15
pubmed: 26861019
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):777-9
pubmed: 27117246
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):6713-8
pubmed: 27247391
Case Reports Immunol. 2016;2016:5459029
pubmed: 27699073
Acta Neuropathol. 2017 Jan;133(1):139-147
pubmed: 27770235
Nat Commun. 2016 Dec 23;7:13992
pubmed: 28008925
J Allergy Clin Immunol. 2017 Jun;139(6):1995-1997.e9
pubmed: 28087227
MBio. 2017 Aug 15;8(4):
pubmed: 28811340
J Clin Invest. 2017 Dec 1;127(12):4415-4420
pubmed: 29106381
J Med Genet. 2018 May;55(5):298-306
pubmed: 29453195
Hum Vaccin Immunother. 2018;14(9):2158-2162
pubmed: 29482433
J Exp Med. 2018 Oct 1;215(10):2567-2585
pubmed: 30143481
Vaccine. 2019 Aug 14;37(35):4848-4849
pubmed: 30424888
J Clin Immunol. 2019 May;39(4):376-390
pubmed: 31123910
J Virol. 1998 Sep;72(9):7563-8
pubmed: 9696854
J Med Virol. 1998 Oct;56(2):159-67
pubmed: 9746073
J Infect Dis. 1998 Oct;178(4):1095-104
pubmed: 9806040